Back to Search
Start Over
Efficacy of dasatinib against ponatinib-resistant chronic myeloid leukemia cells
- Source :
- Leukemia & Lymphoma. 61:237-239
- Publication Year :
- 2019
- Publisher :
- Informa UK Limited, 2019.
-
Abstract
- Chronic myeloid leukemia (CML) is a hematopoietic stem cell disorder characterized by the Philadelphia chromosome (Ph) which is associated with BCR-ABL fusion protein. ABL tyrosine kinase inhibitor...
- Subjects :
- Cancer Research
Dasatinib
Antineoplastic Agents
Philadelphia chromosome
chemistry.chemical_compound
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
hemic and lymphatic diseases
Humans
Medicine
Protein Kinase Inhibitors
neoplasms
business.industry
Ponatinib
Imidazoles
Hematopoietic stem cell
Myeloid leukemia
ABL Tyrosine Kinase
Hematology
medicine.disease
Fusion protein
Pyridazines
medicine.anatomical_structure
Oncology
chemistry
Cancer research
business
medicine.drug
Subjects
Details
- ISSN :
- 10292403 and 10428194
- Volume :
- 61
- Database :
- OpenAIRE
- Journal :
- Leukemia & Lymphoma
- Accession number :
- edsair.doi.dedup.....5767b4dd72a91d85f4910ea1d0b5ce5a
- Full Text :
- https://doi.org/10.1080/10428194.2019.1660971